As of 2025-06-13, the Intrinsic Value of Dolby Laboratories Inc (DLB) is 60.34 USD. This Dolby valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 75.24 USD, the upside of Dolby Laboratories Inc is -19.80%.
The range of the Intrinsic Value is 44.57 - 103.47 USD
Based on its market price of 75.24 USD and our intrinsic valuation, Dolby Laboratories Inc (DLB) is overvalued by 19.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 44.57 - 103.47 | 60.34 | -19.8% |
| DCF (Growth 10y) | 46.67 - 100.39 | 61.19 | -18.7% |
| DCF (EBITDA 5y) | 47.52 - 52.97 | 49.24 | -34.6% |
| DCF (EBITDA 10y) | 48.20 - 56.34 | 51.33 | -31.8% |
| Fair Value | 13.36 - 13.36 | 13.36 | -82.25% |
| P/E | 60.96 - 101.40 | 70.50 | -6.3% |
| EV/EBITDA | 44.04 - 53.41 | 49.94 | -33.6% |
| EPV | 34.21 - 42.00 | 38.11 | -49.4% |
| DDM - Stable | 16.19 - 45.20 | 30.70 | -59.2% |
| DDM - Multi | 22.63 - 47.20 | 30.40 | -59.6% |
| Market Cap (mil) | 7,228.31 |
| Beta | 0.81 |
| Outstanding shares (mil) | 96.07 |
| Enterprise Value (mil) | 6,601.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.43% |
| Cost of Debt | 5.00% |
| WACC | 8.37% |